$MRK Q3 '26 Earnings Results & Recap
• Reported GAAP EPS of $2.49 down -3.49% YoY
• Reported revenue of $18.09B up 4.68% YoY
• Merck & Co. raised and narrowed full-year 2026 sales outlook to $66.8B to $67.3B and non-GAAP EPS outlook to $2.77 to $2.82, including one-time SciBrunch charge.